|
Clinical Relevance of Targeting the Gastrin-Releasing Peptide Receptor, Somatostatin Receptor 2, or Chemokine C-X-C Motif Receptor 4 in Breast Cancer for Imaging and Therapy
|
09 February 2017 |
|
Effect of Subcutaneous Sterile Vitamin E Ointment on Incisional Surgical Site Infection after Elective Laparoscopic Colorectal Cancer Surgery
|
08 February 2017 |
|
Early life sun exposure, vitamin D-related gene variants, and risk of non-Hodgkin lymphoma
|
07 February 2017 |
|
Antagonists of growth hormone-releasing hormone receptor induce apoptosis specifically in retinoblastoma cells
|
03 February 2017 |
|
Review: Receptor Targeted Nuclear Imaging of Breast Cancer
|
03 February 2017 |
|
Vitamin D in hematological disorders and malignancies
|
31 January 2017 |
|
A Role for Vitamin D in the Gastro-Entero-Pancreatic Neuroendocrine Neoplasms Outcome: Report on a Series from a Single Institute
|
27 January 2017 |
|
Growth hormone-releasing hormone receptor antagonists inhibit human gastric cancer through downregulation of PAK1-STAT3/NF-κB signaling
|
27 January 2017 |
|
Targeting NF-κB/AP-2β signaling to enhance antitumor activity of cisplatin by melatonin in hepatocellular carcinoma cells
|
27 January 2017 |
|
Anticancer activity of all-trans retinoic acid-loaded liposomes on human thyroid carcinoma cells
|
25 January 2017 |